Clinical Trial

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Study acronym: TEMEC
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-07
Trial Details
NCT Number NCT04301765
Lead Sponsor Seattle Institute for Biomedical and Clinical Research
Conditions Hypogonadism, Male, Cancer, Fatigue
Enrollment 230 participants
Start Date 2021-01-12
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-06